为治疗缺血性中风提供纳米系统的新兴向交付策略
Jia-Xin Ren1, Hong-Yin Ma1, Wen-Jing Yin1
1Stroke Center, Department of Neurology, the First Hospital of Jilin University, Chang Chun, People's Republic of China.
International journal of nanomedicine
|June 30, 2025
概括
创新的药物输送纳米系统通过克服当前治疗方法的局限性,为缺血性中风治疗提供了新的希望. 这些智能系统针对大脑,可控地释放药物,并改善神经保护,增强中风恢复结果.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 神经科学是一个神经科学.
背景情况:
- 缺血性中风是全球死亡和残疾的主要原因.
- 目前对缺血性中风的治疗有局限性,包括狭窄的治疗窗口,单一的目标和副作用.
- 血脑屏障 (BBB) 和后缺血性变化使中风治疗复杂化.
研究的目的:
- 审查用于缺血性中风治疗的创新药物输送纳米系统.
- 突出跨越BBB并实现可控药物释放的战略.
- 讨论这些纳米系统临床转化方面的挑战和潜在解决方案.
主要方法:
- 审查药物输送纳米材料的最新进展.
- 对BBB透和目标交付的智能纳米系统设计的分析.
- 探索响应和控制药物释放机制的策略.
主要成果:
- 多功能药物输送纳米系统可以有效地穿越BBB以准缺血区域.
- 智能纳米系统通过智能分子切换实现精确的药物积累和可控释放.
- 结合策略可以提高药物定位,扩大治疗窗口,改善神经保护.
结论:
- 药物输送纳米系统代表了新型缺血性中风治疗的强大策略.
- 向传递纳米系统可以协同提高治疗疗效和神经保护作用.
- 应对临床翻译,药物装载和安全等挑战对于未来的发展至关重要.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
167
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167
Ischemic Stroke ll: Pathophysiology
74
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
74


